Drug intelligence / Profile preview

cycloleucine

Development stage
Preclinical
Modality
Small Molecules
01

Overview

Cycloleucine is a non-metabolizable synthetic amino acid formed by the cyclization of leucine. It acts as a specific and reversible inhibitor of nucleic acid methylation, particularly by inhibiting S‑adenosyl-methionine-mediated methylation. Cycloleucine is also an antagonist at the glycine site of the NMDA (N-methyl-D-aspartic acid) receptor and has been shown to have cytostatic, antineoplastic, immunosuppressive, and anxiolytic effects in preclinical studies. It is widely used as a research tool in neuroscience, protein synthesis studies, plant biology, and biochemical research to investigate enzyme mechanisms and metabolic pathways[1][2][3][4][5][10].

Other names
cycloleucine1-amino-1-cyclopentanecarboxylic acid1-aminocyclopentane-1-carboxylic acid1-amino cyclopentane carboxylic acidCyclo-leucineCycloleucin
02

Targets

MAT (Monoamine transporters)N-methyl-D-aspartate receptor glycine site (NMDAR glycine site)

Beyond the preview

Go deeper on cycloleucine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cycloleucine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call